Quality of Life in Paediatric Survivors of Medulloblastoma

Area of Science:

• Neuro-oncology
• Pediatric Oncology
• Quality of Life Research

Background:

• Medulloblastoma (MB) is a common malignant pediatric brain tumor originating in the cerebellum.
• Standard treatment involves surgical resection, craniospinal radiation, and chemotherapy.
• Long-term outcomes and quality of life (QoL) for MB survivors require thorough assessment.

Purpose of the Study:

• To review and synthesize current literature on the quality of life (QoL) in medulloblastoma (MB) survivors.
• To identify the specific domains of QoL most affected in MB survivors.
• To explore predictors associated with diminished QoL in this population.

Main Methods:

• Systematic literature review of studies focusing on medulloblastoma survivors.
• Analysis of reported neurocognitive, intellectual, social, and overall functioning.
• Identification of factors correlating with poorer QoL outcomes.

Main Results:

• MB survivors exhibit significantly compromised QoL, including deficits in neurocognitive function and intelligence quotient (IQ).
• Impaired social functioning, reduced school performance, unemployment, and social isolation are prevalent.
• Caregiver burden is substantial, and survivor self-assessment of performance may differ from objective or caregiver ratings.
• Predictors of worse QoL include younger age at diagnosis, hydrocephalus, shunt placement, altered mental status, incomplete resection, and metastatic disease.

Conclusions:

• Medulloblastoma survivors face profound long-term challenges impacting their quality of life.
• Early diagnosis, aggressive treatment, and presence of metastasis are linked to worse outcomes.
• Multidisciplinary support is crucial for addressing the complex needs of MB survivors and their families.